Long term follow-up report of cardiac toxicity in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation

BACKGROUND: Tandem autologous hematopoietic stem cell transplantation (ta-HSCT) is a standard treatment for multiple myeloma (MM). Patients receive a high-dose cyclophosphamide (CY), followed by two myeloablative cycles of melphalan (MEL). There are scarce data about long term cardiotoxicity. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Kozelj, Mirta, Zver, Samo, Zadnik, Vesna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita, Warsaw 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691086/
https://www.ncbi.nlm.nih.gov/pubmed/23801913
http://dx.doi.org/10.2478/raon-2013-0019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691086/
https://www.ncbi.nlm.nih.gov/pubmed/23801913
http://dx.doi.org/10.2478/raon-2013-0019

Ejemplares similares